Validated Production Workflows · 4–8 Week Pilot Deployment

High-Impact GxP Agent Workflow Solutions

Purpose-built multi-agent architectures for the highest-friction regulated life sciences workflows—complete with 21 CFR Part 11 human electronic signature boundaries, EU GMP Annex 11/22 audit trails, and GAMP 5 validation packages.

Scope a 4–8 Week Pilot Browse All 40+ Use Cases

Quality SuiteGenerative Tier · Part 11 Gate

AI Deviation Investigation & CAPA Root-Cause Automation

GxP Agents automates pharmaceutical deviation triage, RAG-powered 24-month historical recurrence clustering across QMS/MES/LIMS records, and structured 5-Why / Ishikawa (Fishbone) root-cause investigation packets under 21 CFR 211.192, ICH Q9(R1), and 21 CFR Part 11—reducing average deviation cycle time by 62% while preserving mandatory QA electronic signature authority.

62%

Reduction in Deviation Cycle Time

78%

Drop in Overdue CAPAs

$2.1M

Estimated Annual QA Cost Avoided

21 CFR 211.19221 CFR Part 11ICH Q9(R1) & Q10ISPE GAMP 5 (2nd Ed.) & FDA CSA

View Architecture & Benchmarks Book Workflow Demo

Manufacturing SuiteGenerative Tier · Part 11 Gate

Automated Batch Record Review & Review-by-Exception (RBE)

GxP Agents automates end-to-end Batch Manufacturing Record (BMR) and Electronic Batch Record (eBR) verification and Review-by-Exception (RBE) across MES, LIMS Certificates of Analysis, scanned hybrid paper logbooks (AI-OCR), and ERP material genealogy—cutting batch review cycle time by 73%, catching 99.4% of OOS/OOT and documentation discrepancies pre-QA, and freeing 6,720+ QA hours annually.

73%

Faster Batch Record Review

99.4%

Pre-QA Exception Detection Rate

6,720+

Annual QA Review Hours Freed

21 CFR 211.188 & 211.192EU GMP Annex 11 & Annex 2221 CFR Part 11

View Architecture & Benchmarks Book Workflow Demo

Regulatory Affairs SuiteGenerative Tier · Part 11 Gate

AI eCTD Submission Readiness & Regulatory CMC Cross-Verification

GxP Agents automates regulatory eCTD dossier assembly, Module 2 to Module 3 CMC specification reconciliation, and agency guidance surveillance—accelerating submission readiness by 41% and eliminating cross-document data inconsistencies before FDA or EMA filing.

41%

Faster IND/NDA Dossier Assembly

312

Cross-Module Discrepancies Caught

FDA Refuse-to-File / Clinical Hold Issues

ICH M4 (eCTD)FDA AI Drug Development Guidance (Jan 2025)21 CFR Part 11

View Architecture & Benchmarks Book Workflow Demo

Safety & Pharmacovigilance SuiteGenerative Tier · Part 11 Gate

Pharmacovigilance ICSR Intake, MedDRA Coding & Safety Narrative Automation

GxP Agents automates multi-channel adverse event intake, ICH E2B(R3) field extraction, MedDRA term coding, seriousness assessment support, and clinical case narrative drafting—reducing per-case processing time by up to 65% while safeguarding 7-day and 15-day expedited FDA/EMA reporting compliance.

65%

Reduction in ICSR Case Processing Time

15-Day

Expedited SLA Compliance Protected

100%

Human Medical Reviewer Sign-Off

21 CFR 314.80 & 600.80EMA GVP Module VIICH E2B(R3)

View Architecture & Benchmarks Book Workflow Demo

Cybersecurity SuiteAssistive Tier · Part 11 Gate

GxP Vendor Cybersecurity Risk Assessment (TPRM) & Continuous Qualification

GxP Agents automates third-party vendor cybersecurity assessments, SOC 2 Type II and ISO 27001 control mapping against 21 CFR Part 11 / EU Annex 11, and continuous GxP data-integrity risk scoring—reducing supplier qualification lead times by 70% across cloud LIMS, QMS, CRO, and CDMO ecosystems.

70%

Faster Supplier Qualification Cycle

50-Pt

GxP & Cyber Control Matrix Checked

24/7

Continuous Vendor Posture Monitoring

EU GMP Annex 11 (§ 3 & § 12)FDA Section 524B & Cybersecurity GuidanceEU NIS2 Directive

View Architecture & Benchmarks Book Workflow Demo

Quality SuitePredictive Tier · Part 11 Gate

Continuous FDA & EMA Inspection Readiness & Audit Storyboard Automation

GxP Agents transforms FDA, EMA, and Notified Body inspection preparation from a frantic pre-audit war-room scramble into continuous automated readiness—reconciling SOPs, training records, CAPA effectiveness checks, and validation traceability matrices daily while assembling instant back-room inspection storyboards.

24/7

Continuous Compliance Gap Scanning

< 5 Min

Back-Room Inspection Request Assembly

Zero

Unprepared 483 Repeat-Observation Blind Spots

21 CFR Part 211 & Part 820 (QMSR)FDA Computer Software Assurance (CSA)

View Architecture & Benchmarks Book Workflow Demo

Platform Evaluation Matrix

Why Life Sciences Teams Choose GxP Agents Over Alternatives

How our cross-system multi-agent platform compares against generic enterprise copilots, single-vendor QMS/RIM add-ons, and narrow single-workflow point tools.

Evaluation Requirement	Generic Copilots (DIY LLM / Copilot Studio)	Single-Vendor QMS/RIM AI Add-Ons	Single-Workflow Point Startups	GxP Agents Platform
Cross-System Orchestration	None — requires custom API connectors and brittle prompt engineering	Siloed — locked inside one QMS/RIM vendor database; cannot reconcile SAP + LIMS + MES + QMS	Fragmented — solves 1 isolated workflow; requires 6 separate vendor audits across departments	Unified Multi-Agent Layer across Veeva, TrackWise, MasterControl, SAP, LIMS, Medidata & Argus
21 CFR Part 11 (§ 11.50) Human Signature Gate	Not built in — outputs unverified chat text with no regulated e-signature binding	Applies only to native QMS fields, not cross-system agent reasoning chains	Varies widely; often lacks immutable SHA-256 prompt/citation provenance logs	Mandatory § 11.50 human e-signature gate + append-only § 11.10(e) inference audit trail
EU GMP Annex 22 & FDA CoU Compliance	Open-ended generative LLM behavior prohibited on critical GMP parameters	Generic summarization widgets without Context-of-Use (CoU) credibility bounds	Rarely aligned with EU GMP Annex 22 deterministic boundaries or PCCP change control	Built-in Annex 22 deterministic guardrails, FDA 7-step CoU mapping & PCCP version locks
GAMP 5 / FDA CSA Validation Package	6–12 months of internal DIY CSV/CSA authoring from scratch	Customer remains responsible for validating custom AI workflow configurations	Lightweight startup templates that often stall in enterprise QA/CSV committee review	Turnkey 4–8 week IQ/OQ/PQ validation package + optional independent USDM CSA sign-off
Progressive Oversight (Earned Trust)	Static 100% manual re-reading of every output forever	Binary on/off feature flags with no statistical confidence gating	Fixed workflow rules without multi-tier progression	3-Tier Earned Trust (Assistive → Generative → Predictive) scaling from Close to Exception review

How does GxP Agents compare to single-vendor QMS AI add-ons like Veeva AI, MasterControl AI, or TrackWise AI?

Single-vendor QMS and RIM AI add-ons operate only inside their own database. However, real GxP workflows—such as root-cause deviation investigations, batch record Review-by-Exception (RBE), and eCTD Module 3 CMC verification—require reconciling data across Veeva, TrackWise, SAP ERP, LIMS, MES, and Oracle Argus simultaneously. GxP Agents sits as a validated multi-agent orchestration layer across your entire existing system stack without rip-and-replace.

Why choose GxP Agents instead of building custom agents in Microsoft Copilot Studio or ChatGPT Enterprise?

Horizontal enterprise copilots do not include 21 CFR Part 11 (§ 11.50) electronic signature meaning bindings, EU GMP Annex 22 deterministic boundaries, ALCOA+ citation provenance logs, or pre-validated GAMP 5 / FDA CSA IQ/OQ/PQ documentation. Building those regulated controls in-house typically takes 6–12 months before a single workflow passes QA validation, whereas GxP Agents deploys a pre-validated domain pilot in 4–8 weeks.

How does GxP Agents differ from single-workflow pharma AI point startups?

Point-solution startups typically address only a single narrow task (such as OCR batch review or standalone deviation writing), forcing life sciences IT and QA teams to conduct separate vendor security assessments, SOC 2 audits, and CSV validations for every department. GxP Agents provides 8 unified domain suites (47 validated workflows) on a single SOC 2 Type II / ISO 27001 / 21 CFR Part 11 governance architecture, backed by USDM Life Sciences as strategic sponsor and optional third-party validation partner.